Insider · CIK 0001458643

CHAUDHURI BHASKAR

Reports to the SEC for 5 companies · IRVINE, CA

sec.gov

Transactions

Companies

Filings

CIK

0001458643

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,417 sh	—	—	2,417
2026-06-25	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,837 sh	—	—	3,837
2026-06-12	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,954 sh	—	—	11,654
2026-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,954 sh	—	—	0
2025-06-13	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	8,700
2025-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2025-06-12	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+20.6K sh	—	—	20,568
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,954 sh	—	—	2,954
2025-06-12	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,540 sh	—	—	4,540
2025-06-12	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+7,609 sh	—	—	867,826
2024-06-24	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,350 sh	—	—	0
2024-06-24	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,350 sh	—	—	5,350
2024-06-14	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+10.1K sh	—	—	860,217
2024-06-14	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+27.1K sh	—	—	27,052
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2024-06-13	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+3,350 sh	—	—	3,350
2023-06-22	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2023-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	0
2023-06-16	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	—	—	2,000
2023-05-31	ARQTArcutis Biotherapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+12.2K sh	—	—	12,220
2023-05-31	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,375 sh	—	—	850,078
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,000 sh	—	—	7,000
2022-06-16	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Director	AAward	+2,000 sh	—	—	2,000
2022-06-01	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,796
2022-06-01	ARQTArcutis Biotherapeutics, Inc.A Award	Director	AAward	+4,312 sh	—	—	845,703
2021-06-25	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−6,755 sh	$27.50	−$186K	841,391
2021-06-24	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−729 sh	$27.50	−$20K	848,146
2021-06-21	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−2,516 sh	$27.50	−$69.2K	848,875
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-15	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2021-06-09	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+13.4K sh	—	—	13,391
2021-06-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−10K sh	$27.50	−$275K	851,391
2021-04-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−1,280 sh	$28.53	−$36.5K	861,391
2021-04-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−1,280 sh	$28.53	−$36.5K	861,391
2021-04-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−8,720 sh	$27.99	−$244K	862,671
2021-04-20	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−8,720 sh	$27.99	−$244K	862,671
2021-03-22	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−4,992 sh	$31.43	−$157K	871,391
2021-03-22	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−5,008 sh	$30.77	−$154K	876,383
2021-02-22	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−2,789 sh	$35.97	−$100K	881,391
2021-02-22	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−7,211 sh	$35.34	−$255K	884,180
2021-02-01	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−9,949 sh	$33.25	−$331K	891,391
2021-01-29	ARQTArcutis Biotherapeutics, Inc.S Sale	Director	SSale	−51 sh	$27.50	−$1,402.5	901,340
2021-01-04	Teligent, Inc.Stock OptionA Award	Director	AAward	+2,000 sh	—	—	2,000
2020-02-27	ARQTArcutis Biotherapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24K sh	—	—	24,000
2020-02-04	ARQTArcutis Biotherapeutics, Inc.C Conversion	Director	CConversion	+37.5K sh	—	—	901,391
2020-02-04	ARQTArcutis Biotherapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−50K sh	—	—	0
2020-02-04	ARQTArcutis Biotherapeutics, Inc. · Series A Preferred StockC Conversion	Director	CConversion	−37.5K sh	—	—	0
2020-02-04	ARQTArcutis Biotherapeutics, Inc.C Conversion	Director	CConversion	+50K sh	—	—	49,981
2020-01-02	Teligent, Inc.Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000

Recent filings

Accepted (ET)
Jun 294
CHAUDHURI BHASKAR0001458643-26-000004
SEC(opens sec.gov)
Jun 164
CHAUDHURI BHASKAR0001458643-26-000002
SEC(opens sec.gov)
Jun 164
CHAUDHURI BHASKAR0001819790-25-000094
SEC(opens sec.gov)
Jun 164
CHAUDHURI BHASKAR0002065881-25-000022
SEC(opens sec.gov)
Jun 254
CHAUDHURI BHASKAR0001819790-24-000098
SEC(opens sec.gov)
Jun 184
CHAUDHURI BHASKAR0001787306-24-000099
SEC(opens sec.gov)
Jun 144
CHAUDHURI BHASKAR0001819790-24-000083
SEC(opens sec.gov)
Jun 264
CHAUDHURI BHASKAR0001819790-23-000060
SEC(opens sec.gov)
Jun 214
CHAUDHURI BHASKAR0001819790-23-000045
SEC(opens sec.gov)

Companies

Address

C/O TARSUS PHARMACEUTICALS, INC. 17700 LAGUNA CANYON ROAD, FLOOR 4

IRVINE, CA, 92618